Market revenue in 2022 | USD 885.4 million |
Market revenue in 2030 | USD 1,792.3 million |
Growth rate | 9.2% (CAGR from 2022 to 2030) |
Largest segment | Prokaryotic |
Fastest growing segment | Mammalian cell |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Prokaryotic, Mammalian cell, Insect cell, Yeast |
Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Merck & Co Inc, New England Biolabs, Promega, Qiagen NV, Takara Bio Inc, LGC Group, Oxford Nanopore Technologies PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to protein expression market will help companies and investors design strategic landscapes.
Prokaryotic was the largest segment with a revenue share of 41.28% in 2023. Horizon Databook has segmented the Europe protein expression market based on prokaryotic, mammalian cell, insect cell, yeast covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe protein expression market, including forecasts for subscribers. This continent databook contains high-level insights into Europe protein expression market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account